Skip to main content
. 2012 Nov 1;143(3):605–612. doi: 10.1378/chest.12-1788

Figure 2.

Figure 2.

Calculated therapeutic gain for datasets derived from patients with pathologic esophageal acid exposure and populations including patients with normal esophageal acid exposure. aPercentage change in symptom score; bPercentage change in proportion of responders.